Publication | Closed Access

Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial

Pancreatic CancerGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaMedicinePharmacologyRandomised Phase 2Cancer TreatmentOncologyRadiation OncologyMolecular Oncology